CVS Health (CVS) Tops Q4 EPS by 19c, Beats on Revenue; Offers FY25 EPS Guidance
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $104.72 -0.09%
EPS Growth %: +1.1%
Financial Fact:
Cost of revenues: 37.12B
Today's EPS Names:
PKE, LNN, More
EPS Growth %: +1.1%
Financial Fact:
Cost of revenues: 37.12B
Today's EPS Names:
PKE, LNN, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q4 EPS of $1.19, $0.19 better than the analyst estimate of $1.00. Revenue for the quarter came in at $97.7 billion versus the consensus estimate of $96.97 billion.
GUIDANCE:
CVS Health sees FY2025 EPS of $5.75-$6.00, versus the consensus of $5.97.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Trump dodges divulging if U.S. will take a 5% stake in OpenAI - CNBC Interview
- Crusoe in talks to raise $3B in funding - Bloomberg
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
